BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33722087)

  • 1. Endothelial deletion of PKCδ prevents VEGF inhibition and restores blood flow reperfusion in diabetic ischemic limb.
    Croteau L; Mercier C; Fafard-Couture É; Nadeau A; Robillard S; Breton V; Guay A; Lizotte F; Despatis MA; Geraldes P
    Diab Vasc Dis Res; 2021; 18(2):1479164121999033. PubMed ID: 33722087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Impaired Ischemia-Induced PDGF (Platelet-Derived Growth Factor) Signaling Actions and Vessel Formation Through the Activation of Scr Homology 2-Containing Phosphatase-1.
    Mercier C; Brazeau T; Lamoureux J; Boisvert E; Robillard S; Breton V; Paré M; Guay A; Lizotte F; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2469-2482. PubMed ID: 34320834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs.
    Lizotte F; Paré M; Denhez B; Leitges M; Guay A; Geraldes P
    Diabetes; 2013 Aug; 62(8):2948-57. PubMed ID: 23557702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
    Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
    FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of angiotensin type 2 receptor prevents endothelial nitric oxide synthase glutathionylation and nitration in ischaemic abductor muscle of diabetic mice.
    Robillard S; Mercier C; Breton V; Paquin-Veillette J; Guay A; Lizotte F; Geraldes P
    Diab Vasc Dis Res; 2020; 17(1):1479164119883978. PubMed ID: 31726870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.
    Yan J; Tie G; Park B; Yan Y; Nowicki PT; Messina LM
    J Vasc Surg; 2009 Dec; 50(6):1412-22. PubMed ID: 19837544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation.
    Most P; Lerchenmüller C; Rengo G; Mahlmann A; Ritterhoff J; Rohde D; Goodman C; Busch CJ; Laube F; Heissenberg J; Pleger ST; Weiss N; Katus HA; Koch WJ; Peppel K
    Circ Res; 2013 Jan; 112(1):66-78. PubMed ID: 23048072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor protein p53 negatively regulates ischemia-induced angiogenesis and arteriogenesis.
    Pfaff MJ; Mukhopadhyay S; Hoofnagle M; Chabasse C; Sarkar R
    J Vasc Surg; 2018 Dec; 68(6S):222S-233S.e1. PubMed ID: 30126780
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
    Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
    Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BuZangTongLuo decoction improved hindlimb ischemia by activating angiogenesis and regulating gut microbiota in diabetic mice.
    Zheng J; Chen M; Ye C; Sun X; Jiang N; Zou X; Yang H; Liu H
    J Ethnopharmacol; 2020 Feb; 248():112330. PubMed ID: 31654796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.
    Huang PH; Chen JW; Lin CP; Chen YH; Wang CH; Leu HB; Lin SJ
    Cardiovasc Diabetol; 2012 Aug; 11():99. PubMed ID: 22894755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial-specific transgenesis of TNFR2 promotes adaptive arteriogenesis and angiogenesis.
    Luo Y; Xu Z; Wan T; He Y; Jones D; Zhang H; Min W
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1307-14. PubMed ID: 20395596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.
    Sachdev U; Cui X; Tzeng E
    J Vasc Surg; 2013 Aug; 58(2):460-9. PubMed ID: 23414695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice.
    Salis MB; Graiani G; Desortes E; Caldwell RB; Madeddu P; Emanueli C
    Diabetologia; 2004 Jun; 47(6):1055-63. PubMed ID: 15184980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.